Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro (Q28324069)
scientific article published on October 1, 1991
Language:
Current Data About Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro
(P31) (Q13442814)

(P50) (Q87874621)
(P1545) 6
(P1932) J J Eron

(Q15070077)
(P1545) 4
(P1932) T. C. Chou
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

(Q124629306)
(P1545) 7
(P1932) R. T. D'Aquila
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

(P304) 646-55

(P407) (Q1860)

(P433) 4

(P478) 164

(P577) +1991-10-00T00:00:00Z

(P921) (Q422606)
(P887)

(Q198504)
(P887)

(P953) http://academic.oup.com/jid/article-pdf/164/4/646/6462198/164-4-646.pdf
(P2701)
(P248)
(P356) 10.1093/INFDIS/164.4.646
(P854) https://api.crossref.org/works/10.1093/INFDIS/164.4.646
(P813) Sunday, November 6, 2022

(P1433) (Q4051141)

(P1476) "Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro" (language: en)

"Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro" (language: en)
(P248)
(P356) 10.1093/INFDIS/164.4.646
(P854) https://api.crossref.org/works/10.1093/INFDIS/164.4.646
(P813) Sunday, November 6, 2022

(P2093) V. A. Johnson
(P1545) 1
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

D. P. Merrill
(P1545) 2
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

J. A. Videler
(P1545) 3
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

R. E. Byington
(P1545) 5
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

M. S. Hirsch
(P1545) 8
(P248)
(P698) 1716649
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1716649
(P813) Sunday, November 6, 2022

other details
description scientific article published on October 1, 1991

External Links
(P356) 10.1093/INFDIS/164.4.646
(P698) 1716649